(Q40082780)

17 September 2017

title

Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells (English)

1 reference

17 September 2017

Tao Yang

1

1 reference

17 September 2017

Min-Koo Choi

2

1 reference

17 September 2017

Fu-De Cui

3

1 reference

17 September 2017

Seung-Jin Lee

4

1 reference

17 September 2017

Suk-Jae Chung

5

1 reference

17 September 2017

Chang-Koo Shim

6

1 reference

17 September 2017

Dae-Duk Kim

7

1 reference

17 September 2017

publication date

9 September 2007

1 reference

17 September 2017

published in

Pharmaceutical Research

1 reference

17 September 2017

volume

24

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

2402-2411

1 reference

Taxol suppresses dynamics of individual microtubules in living human tumor cells

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9425-Y

Interaction between Herceptin and taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9425-Y

Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9425-Y

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9425-Y

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

21 January 2018

1 reference

12 December 2020

Immunoliposomes for the targeted delivery of antitumor drugs

1 reference

12 December 2020

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs

1 reference

12 December 2020

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation

1 reference

12 December 2020

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

1 reference

12 December 2020

Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia

1 reference

12 December 2020

Improving the efficacy of antibody-based cancer therapies

1 reference

12 December 2020

Synergistic interaction of anticancer agents: a cellular perspective

1 reference

12 December 2020

Controlling liposome blood clearance by surface-grafted polymers

1 reference

12 December 2020

In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer

1 reference

12 December 2020

Trastuzumab: updates and future issues

1 reference

12 December 2020

Influence of cholesterol on the association of plasma proteins with liposomes

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

Paclitaxel in cancer therapy

1 reference

12 December 2020

Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells.

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes

1 reference

12 December 2020

Microtubules as a target for anticancer drugs

1 reference

12 December 2020

Strategies to target HER2/neu overexpression for cancer therapy

1 reference

12 December 2020

1 reference

12 December 2020

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel

1 reference

12 December 2020

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

1 reference

12 December 2020

Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells

1 reference

12 December 2020

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

1 reference

12 December 2020

Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

1 reference

12 December 2020

1 reference

12 December 2020

Liposomal formulations of anticancer drugs: selectivity and effectiveness

1 reference

12 December 2020

Treatment of breast cancer

1 reference

12 December 2020

Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells.

1 reference

12 December 2020

Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development

1 reference

12 December 2020

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

12 December 2020

Immunoliposomes for cancer treatment

1 reference

12 December 2020

Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia

1 reference

12 December 2020

Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.

1 reference

12 December 2020

Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities

1 reference

12 December 2020

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

12 December 2020

Trastuzumab and chemotherapeutics: drug interactions and synergies.

1 reference

12 December 2020

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome

1 reference

12 December 2020

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

12 December 2020

10.1007/S11095-007-9425-Y

Identifiers

DOI

1 reference

17 September 2017

1 reference